Table 1.
Characteristic | n (%) | Mean (SD) | Comparison | Estimated HR | p |
---|---|---|---|---|---|
Sex | Male vs. female | 1.43 | 0.114 | ||
Female | 34 (38) | ||||
Male | 56 (62) | ||||
Previous chemotherapy | Yes vs. no | 0.96 | 0.850 | ||
No | 66 (73) | ||||
Yes | 24 (27) | ||||
Age | 61.4 (9.2) | 5-year increase | 0.99 | 0.790 | |
ECOG PS* | Poor vs. good | 1.47 | 0.103 | ||
Good (0 or 1) | 60 (67) | ||||
Poor (2 or 3) | 30 (33) | ||||
SF-12** general health item | Fair, poor vs. | 1.55 | 0.049 | ||
Fair or poor | 42 (47) | excellent, very good, | |||
Excellent, very good, or good | 48 (53) | good | |||
Mean MDASI interference | 2.6 (2.3) | One-point increase | 1.19 | 0.002 | |
Mean MDASI symptom severity (five items) | 2.4 (1.7) | One-point increase | 1.11 | 0.138 | |
SF-12 physical component summary | 35.6 (11.4) | Five-point decrease | 1.08 | 0.093 | |
SF-12 mental component summary | 47.4 (10.7) | Five-point decrease | 1.01 | 0.824 |
Fifteen patients (17%) had ECOG PS = 0; 45 (50%) had ECOG PS = 1; 27 (30%) had ECOG PS = 2; three (3%) had ECOG PS = 3
Five patients (6%) responded excellent; 16 (18%), very good; 27 (30%), good; 33 (37%), fair; nine(10%), poor